--- title: "Citizens Jmp Increases Fidelis Insurance (NYSE:PLGO) Price Target to $28.00" type: "News" locale: "en" url: "https://longbridge.com/en/news/292328902.md" description: "Citizens Jmp raised Fidelis Insurance's (NYSE:PLGO) price target from $27.00 to $28.00, maintaining a 'market outperform' rating. This follows similar upgrades by other analysts: UBS and KBW raised targets to $29.00 with 'buy'/'outperform' ratings, while Barclays lifted its target to $24.00. Weiss Ratings initiated coverage with a 'buy (b)' rating, and Zacks upgraded the stock to 'strong-buy'. The consensus rating is 'Moderate Buy' with an average target of $26.60." datetime: "2026-07-10T13:42:49.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/292328902.md) - [en](https://longbridge.com/en/news/292328902.md) - [zh-HK](https://longbridge.com/zh-HK/news/292328902.md) generator: "portal-rs" --- # Citizens Jmp Increases Fidelis Insurance (NYSE:PLGO) Price Target to $28.00 Fidelis Insurance (NYSE:PLGO - Get Free Report) had its price target raised by equities research analysts at Citizens Jmp from $27.00 to $28.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm currently has a "market outperform" rating on the stock. Citizens Jmp's target price indicates a potential upside of 11.53% from the company's previous close. Get **Fidelis Insurance** alerts: Several other equities analysts have also commented on the company. UBS Group increased their price objective on Fidelis Insurance from $28.00 to $29.00 and gave the company a "buy" rating in a research report on Wednesday. Barclays lifted their target price on shares of Fidelis Insurance from $22.00 to $24.00 and gave the stock an "equal weight" rating in a research report on Tuesday. Keefe, Bruyette & Woods upped their price target on shares of Fidelis Insurance from $28.00 to $29.00 and gave the company an "outperform" rating in a research report on Wednesday. Weiss Ratings started coverage on Fidelis Insurance in a report on Wednesday, May 13th. They issued a "buy (b)" rating on the stock. Finally, Zacks Research raised Fidelis Insurance from a "strong sell" rating to a "strong-buy" rating in a research note on Thursday, May 28th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $26.60. **Read Our Latest Research Report on PLGO** ## Fidelis Insurance Stock Performance PLGO stock opened at $25.11 on Friday. The business's fifty day moving average price is $23.29. Fidelis Insurance has a fifty-two week low of $14.80 and a fifty-two week high of $25.60. The company has a market cap of $2.17 billion, a P/E ratio of 6.78 and a beta of 0.29. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.70 and a quick ratio of 0.70. Fidelis Insurance (NYSE:PLGO - Get Free Report) last announced its quarterly earnings results on Wednesday, May 13th. The company reported $0.94 earnings per share for the quarter, beating the consensus estimate of $0.75 by $0.19. Fidelis Insurance had a return on equity of 14.44% and a net margin of 15.33%.The company had revenue of $612.20 million during the quarter, compared to analysts' expectations of $577.19 million. Equities analysts predict that Fidelis Insurance will post 3.78 EPS for the current year. ## About Fidelis Insurance (Get Free Report) Fidelis is a leading global provider of bespoke and specialty insurance and reinsurance products. We believe our differentiated underwriting positions us well to generate strong returns across (re) insurance cycles. Current Fidelis is led by Mr. Daniel Burrows who has more than 35 years of experience in the insurance industry and is supported by a highly experienced management team that manages the operations of Current Fidelis based on our founding principles. Following the Separation Transactions, Current Fidelis is positioned as a global, specialty insurance provider with exclusive right of first access to Fidelis MGU's underwriting business during the term of the Framework Agreement. ## Recommended Stories - Five stocks we like better than Fidelis Insurance - Broadcom's $30 Billion Apple Deal: This Chip Giant Is About More than Just AI - IQM's Nasdaq Debut Could Change the Quantum Race for D-Wave - Buyer Beware: These 2 Stocks Charts Just Displayed a Death Cross - PepsiCo’s Dividend Could Turn Patience Into Real Profit *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.* ## Should You Invest $1,000 in Fidelis Insurance Right Now? Before you consider Fidelis Insurance, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fidelis Insurance wasn't on the list. While Fidelis Insurance currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [PLGO.US](https://longbridge.com/en/quote/PLGO.US.md) - [UBS.US](https://longbridge.com/en/quote/UBS.US.md) - [BCS.US](https://longbridge.com/en/quote/BCS.US.md) - [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md) - [AVGO.US](https://longbridge.com/en/quote/AVGO.US.md) - [AAPL.US](https://longbridge.com/en/quote/AAPL.US.md) - [IQM.US](https://longbridge.com/en/quote/IQM.US.md) - [QBTS.US](https://longbridge.com/en/quote/QBTS.US.md) - [PEP.US](https://longbridge.com/en/quote/PEP.US.md) - [QBTS+.US](https://longbridge.com/en/quote/QBTS+.US.md) ## Related News & Research - [Pelagos Insurance Capital (PLGO) Q2 2026 Earnings Call: Premium Growth, Large Losses and Outlook](https://longbridge.com/en/news/295904788.md) - [Fidelis Insurance (NYSE:PLGO) Cut to "Hold" at Zacks Research](https://longbridge.com/en/news/294201937.md) - [89,866 Shares in Accenture PLC $ACN Acquired by Commerzbank Aktiengesellschaft FI](https://longbridge.com/en/news/296195987.md) - [Lawsuit Update: Investors in Fiserv, Inc. (NYSE: FI) shares should contact the Shareholders Foundation](https://longbridge.com/en/news/295829668.md) - [Citizens Jmp Reaffirms "Market Outperform" Rating for Allogene Therapeutics (NASDAQ:ALLO)](https://longbridge.com/en/news/296112335.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**